Your session is about to expire
← Back to Search
Cognitive Processing Therapy for PTSD in Incarcerated Individuals
N/A
Recruiting
Led By Michael R Koenigs, PhD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
18 years old or older
No active symptoms of psychosis that would interfere with the individual's ability to participate in the group
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (two weeks prior to intervention), up to 3 weeks (mid-intervention), up to 8 weeks (one week post-intervention), up to 12 weeks (one month post-treatment), and up to 20 weeks (three months post-treatment)
Awards & highlights
Study Summary
This trial will study the psychological response to group Cognitive Processing Therapy (CPT) in incarcerated men and women with Post-traumatic stress disorder (PTSD). The study will include 2 groups of 10 individuals for both CPT and Therapist-facilitated Support Group in both populations (i.e., 80 participants total; 40F/40M, four CPT groups of 10 (2 Female (F)/2 Male (M)); four Therapist-facilitated Support groups of 10 (2F/2M)). The study will run for up to 2 years. Participants can expect to be participating in study for up to 22 weeks
Who is the study for?
This trial is for incarcerated men and women aged 18 or older with PTSD, who can read at a 4th-grade level or higher, have stable medication use for at least one month, and an IQ of 70 or above. They must be willing to join group therapy but not currently in trauma-focused treatment involving processing of trauma.Check my eligibility
What is being tested?
The study tests how effective Cognitive Processing Therapy (CPT) is compared to Therapist-facilitated Support groups in treating PTSD among the prison population. It involves four groups each for CPT and support sessions over a period of up to 22 weeks.See study design
What are the potential side effects?
While there are no direct physical side effects from these therapies, participants may experience emotional discomfort as they confront traumatic memories during therapy sessions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
I do not have symptoms of psychosis affecting my participation.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (two weeks prior to intervention), up to 3 weeks (mid-intervention), up to 8 weeks (one week post-intervention), up to 12 weeks (one month post-treatment), and up to 20 weeks (three months post-treatment)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (two weeks prior to intervention), up to 3 weeks (mid-intervention), up to 8 weeks (one week post-intervention), up to 12 weeks (one month post-treatment), and up to 20 weeks (three months post-treatment)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in PTSD Checklist for DSM-5 (PCL-5) severity score
Secondary outcome measures
Change in score on the Beck Anxiety Inventory (BAI)
Change in score on the Beck Depression Inventory 2 (BDI-II)
Percentage of participants endorsing 2 or higher on Q9 of BDI-II
+2 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: Therapist-facilitated Support groupExperimental Treatment1 Intervention
Arm = Therapist-facilitated Support Group Group = 4 groups of 10 (40 total; 20F/20M) receive support as active control group for PTSD treatment
Group II: Cognitive Processing Therapy (CPT) groupExperimental Treatment1 Intervention
Arm = Cognitive Processing Therapy (CPT) Group = 4 groups of 10 (40 total; 20F/20M) receive CPT to treat PTSD
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Processing Therapy
2016
N/A
~3400
Find a Location
Who is running the clinical trial?
University of Wisconsin, MadisonLead Sponsor
1,189 Previous Clinical Trials
3,169,466 Total Patients Enrolled
Wisconsin Partnership ProgramOTHER
7 Previous Clinical Trials
378 Total Patients Enrolled
Michael R Koenigs, PhDPrincipal InvestigatorUniversity of Wisconsin, Madison
1 Previous Clinical Trials
70 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.I do not have symptoms of psychosis affecting my participation.I am willing and able to join group therapy sessions.
Research Study Groups:
This trial has the following groups:- Group 1: Therapist-facilitated Support group
- Group 2: Cognitive Processing Therapy (CPT) group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any openings left for participants in this clinical experiment?
"According to the clinicaltrials.gov website, this particular medical research is not presently recruiting any study participants - the initial post was on December 1st 2022 and it was last updated on November 9th 2022. However, there are still 318 other trials actively trying to find patients at present."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger